How to Get Provigil (Modafinil) in Maryland

What Modafinil Is and Why It Requires a Prescription

Modafinil is a wakefulness-promoting agent classified as Schedule IV under the Controlled Substances Act. The FDA approved it in December 1998 under the brand name Provigil, manufactured by Cephalon, for the treatment of excessive daytime sleepiness associated with narcolepsy 1. The approval followed the US Modafinil in Narcolepsy Multicenter Study Group trial, which demonstrated that modafinil 200 mg and 400 mg significantly reduced sleepiness on the Epworth Sleepiness Scale and improved maintenance of wakefulness test latency compared to placebo 2.

Because modafinil carries a low but documented abuse potential, DEA scheduling requires that every dispensing pharmacy receive a valid prescription from a provider holding an active DEA license 3. In Maryland, this means you cannot simply walk into a pharmacy and buy it. You need a prescriber visit, either in person or via telehealth, followed by a prescription transmitted to a licensed pharmacy.

The drug's mechanism is distinct from amphetamines. Modafinil acts primarily through dopamine reuptake inhibition at the dopamine transporter (DAT), and a 2009 PET study by Volkow et al. confirmed occupancy at the DAT in the human brain at therapeutic doses 4. This pharmacological profile gives modafinil a lower risk of dependence than traditional stimulants, which is one reason the DEA assigned it Schedule IV rather than Schedule II.

Who Can Prescribe Provigil in Maryland

Any Maryland-licensed clinician with an active DEA registration is authorized to write a modafinil prescription. This includes physicians (MD and DO), nurse practitioners (NP), and physician assistants (PA). Maryland grants NPs full practice authority under the Maryland Nurse Practice Act, so NPs in the state do not need a collaborative physician agreement to prescribe Schedule IV substances 5.

Sleep medicine specialists and neurologists prescribe modafinil most frequently for narcolepsy. Primary care physicians commonly write modafinil prescriptions for shift-work disorder and as an adjunct in obstructive sleep apnea when CPAP alone fails to resolve residual sleepiness. The American Academy of Sleep Medicine (AASM) practice parameters recommend modafinil as a standard-level treatment for excessive sleepiness in narcolepsy 6.

If your provider is a PA, Maryland law requires a delegation agreement with a supervising physician that includes controlled substance prescribing privileges. Confirm this before your appointment if you plan to see a PA specifically for a modafinil prescription.

Telehealth Prescribing Rules in Maryland

Maryland permits telehealth prescribing of Schedule IV controlled substances. Yes, this includes modafinil. The Maryland Medical Practice Act and the Maryland Board of Physicians allow clinicians to establish a provider-patient relationship via synchronous audio-video telehealth 7. This means a Maryland resident can consult a physician or NP over video, receive a diagnosis, and have the prescription sent electronically to a local pharmacy.

A few requirements apply. The prescriber must hold a Maryland medical license (or be authorized under an interstate compact). The visit must use real-time video. Audio-only telephone calls may be acceptable for follow-up refills under pandemic-era flexibilities, but the initial visit generally requires a video component 7. The prescription must be transmitted as an electronic prescribing for controlled substances (EPCS) transaction, which Maryland mandates for all controlled substance prescriptions under Health-General Article §21-2A-05.

Telehealth is particularly convenient for patients in rural parts of Western Maryland or the Eastern Shore, where sleep specialists may be scarce. Wait times for in-person sleep medicine appointments at academic centers in Baltimore can stretch 4 to 8 weeks, while many telehealth platforms offer initial consultations within 3 to 7 days.

Labs and Documentation Needed Before Prescribing

No single blood test is mandatory before a modafinil prescription, but most responsible clinicians will want baseline data. Here is what Maryland prescribers typically request:

For narcolepsy: An overnight polysomnogram (PSG) followed by a multiple sleep latency test (MSLT) is the diagnostic standard. The AASM scoring manual requires a mean sleep latency of ≤8 minutes and ≥2 sleep-onset REM periods on MSLT for a narcolepsy type 1 diagnosis 8. Insurers almost universally require PSG/MSLT documentation for prior authorization.

For shift-work disorder: A clinical history documenting a rotating or night-shift schedule with associated excessive sleepiness or insomnia is generally sufficient. The ICSD-3 criteria do not require polysomnography for shift-work disorder, though actigraphy data strengthens the case for insurance approval 9.

For obstructive sleep apnea adjunct use: The prescriber will need documentation of CPAP adherence (typically ≥4 hours per night on ≥70% of nights for 30 days) with persistent residual sleepiness despite adequate therapy 10. A 2006 randomized trial by Black and Hirshkowitz showed modafinil 200 mg significantly improved Epworth Sleepiness Scale scores in OSA patients with residual sleepiness on CPAP (ESS drop of 4.4 points vs. 1.0 for placebo, P<0.001) 10.

General labs: A hepatic function panel (AST, ALT) is prudent because modafinil is hepatically metabolized via CYP3A4 1. Some clinicians also check a basic metabolic panel and thyroid-stimulating hormone (TSH) to rule out metabolic causes of fatigue before attributing symptoms to a primary sleep disorder.

Insurance Coverage and Prior Authorization in Maryland

Most commercial insurers in Maryland cover generic modafinil for FDA-approved indications. Brand-name Provigil is rarely covered since the patent expired in 2012 and generics became widely available. Maryland Medicaid (through the HealthChoice managed care organizations) covers modafinil with prior authorization for narcolepsy and shift-work disorder.

Prior authorization requirements are the main barrier. Here is what Maryland plans typically ask for:

1. A confirmed diagnosis of narcolepsy, shift-work disorder, or residual sleepiness in treated OSA.
2. Supporting sleep study results (PSG/MSLT for narcolepsy, CPAP compliance data for OSA).
3. Documentation that non-pharmacologic interventions (sleep hygiene, schedule modification) have been tried or are inappropriate.
4. For off-label uses, many plans will deny coverage outright, though appeals may succeed with supporting literature.

Maryland Insurance Administration regulations require insurers to process standard prior authorization requests within 2 business days and urgent requests within 24 hours 11. In practice, most PA decisions arrive within 24 to 72 hours.

If your PA is denied, Maryland law gives you the right to an expedited external review through the Maryland Insurance Administration. A 2020 systematic review found that modafinil has a number needed to treat (NNT) of approximately 4.7 for clinically meaningful improvement in narcolepsy-related sleepiness, data that can support appeal letters 12.

Cost of Modafinil at Maryland Pharmacies

Generic modafinil 200 mg (30 tablets) at Maryland retail pharmacies typically costs $30 to $350 depending on whether you use insurance. Cash price without insurance at major chains (CVS, Walgreens, Rite Aid) clusters around $150 to $350 for 30 tablets. With commercial insurance and a completed PA, copays range from $15 to $45 at most preferred-tier plans.

Manufacturer discount cards and GoodRx-type coupons can bring cash prices down to $25 to $60 for 30 tablets at select Maryland pharmacies. Brand-name Provigil, when stocked, exceeds $1,200 for 30 tablets at cash price.

Maryland's 503A compounding pharmacies are licensed to dispense modafinil in standard dosage forms when dispensing against a valid prescription, though compounding a commercially available product into the same dosage form is restricted under FDA guidance 13. For patients needing non-standard doses (e.g., 50 mg or 150 mg tablets), a 503A pharmacy in Maryland can legally compound these from bulk powder with a patient-specific prescription.

How to Fill Your Prescription at a Maryland Pharmacy

Once your prescriber sends the EPCS prescription, you can fill it at any licensed Maryland pharmacy. The steps are straightforward:

Step 1: Confirm your pharmacy has modafinil in stock. Supply shortages have occurred periodically. The FDA Drug Shortage Database tracks ongoing availability issues 14.

Step 2: Present valid photo identification. Maryland pharmacies must verify ID for Schedule IV dispensing under COMAR 10.34.28.

Step 3: If your insurance requires PA and it has been approved, the pharmacy can process the claim immediately. If the PA is still pending, you may need to pay cash and seek reimbursement, or wait for approval.

Refills: Schedule IV prescriptions in Maryland allow up to 5 refills within 6 months from the date written, per federal DEA regulations 15. Your prescriber can also write the prescription with refills built in, reducing the need for repeated visits.

Mail-order: Many Maryland insurance plans offer 90-day mail-order supply at reduced copays. Express Scripts, OptumRx, and CVS Caremark all ship Schedule IV medications to Maryland addresses.

Transferring a Provigil Prescription to Maryland

If you are relocating to Maryland from another state, you can transfer an existing modafinil prescription. Federal law permits one transfer of a Schedule IV prescription between pharmacies, and the receiving Maryland pharmacy handles the transfer directly with the originating pharmacy. You cannot transfer a prescription that has already been transferred once.

For patients moving permanently, the more practical approach is to establish care with a Maryland-licensed prescriber who can write new prescriptions going forward. If you have recent sleep study documentation, most prescribers will continue the medication without repeating diagnostic testing, provided the records are available for review. The AASM clinical practice guideline notes that repeat MSLT is not routinely necessary in patients with an established narcolepsy diagnosis 8.

Safety Monitoring and Follow-Up

Modafinil is well tolerated in most patients, but ongoing monitoring matters. The most common adverse effects in clinical trials were headache (34% vs. 23% placebo), nausea (11% vs. 3% placebo), and nervousness (7% vs. 3% placebo), as reported in the prescribing information 1. Serious skin reactions, including Stevens-Johnson syndrome, have been reported rarely, and the FDA label carries a warning about this risk 1.

Drug interactions are clinically relevant. Modafinil induces CYP3A4 and inhibits CYP2C19. It reduces the efficacy of hormonal contraceptives (ethinyl estradiol exposure decreases by approximately 18%), so patients using oral contraceptives should use backup or alternative contraception 16. This interaction persists for one full cycle after stopping modafinil.

Maryland prescribers typically schedule follow-up visits every 3 to 6 months for stable patients. At follow-up, expect a review of sleep diary data, side effect screening, and assessment of continued efficacy using validated tools such as the Epworth Sleepiness Scale 17.

A 12-month open-label extension study by Schwartz et al. demonstrated sustained efficacy of modafinil 200 to 400 mg in narcolepsy patients, with no evidence of tolerance development over one year of daily use 18. Blood pressure and heart rate should be checked periodically, as modafinil can cause modest increases in systolic blood pressure (mean 1 to 3 mmHg) in some patients.

Off-Label Use Considerations in Maryland

Prescribers in Maryland may write modafinil for off-label indications including fatigue related to multiple sclerosis, ADHD, and depression-associated fatigue. However, insurance coverage for off-label use is inconsistent. A Cochrane review of modafinil for cognitive function in non-sleep-disordered populations found limited and inconsistent evidence of benefit 19. Maryland Medicaid generally does not cover off-label modafinil prescriptions without a formal exception request and supporting peer-reviewed evidence.

For patients seeking modafinil for cognitive enhancement without a diagnosed sleep disorder, expect to pay cash price. This is an area where informed consent documentation becomes especially important, and Maryland Board of Physicians guidelines expect prescribers to document the rationale for off-label use in the medical record.